Literature DB >> 21469198

Osteopontin polymorphic susceptibility factor for Parkinson's disease among patients with Gaucher disease.

Avigayil Ribner1, Gheona Altarescu, Ari Zimran, Deborah Elstein.   

Abstract

BACKGROUND: There is an increased incidence of Parkinson's disease among obligate carriers of the common glucocerebrosidase mutations, and among patients with Parkinson disease there is an increased number who are carriers of glucocerebrosidase mutations. A Gaucher mutation is considered a susceptibility factor for Parkinson's disease. Osteopontin single-nucleotide polymorphism-66 is associated with Lewy body disease and considered a susceptibility factor. The aim of this study was to ascertain whether Gaucher patients with parkinsonism carry the osteopontin single-nucleotide polymorphism-66 polymorphic genotype TT to a greater extent than other Gaucher patients.
METHODS: Seventy adult patients with at least 1 allele having the common N370S Gaucher mutation including 10 patients with Parkinson's disease were included.
RESULTS: There was no statistically significant difference in incidence of the TT genotype in patients with clinically symptomatic Parkinson's disease (88.9%) and other Gaucher patients (72.1%).
CONCLUSIONS: This may partly explain the increased incidence of Parkinson's disease associated with Gaucher mutations.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21469198     DOI: 10.1002/mds.23595

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  2 in total

1.  Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.

Authors:  Roy N Alcalay; Tama Dinur; Timothy Quinn; Karina Sakanaka; Oren Levy; Cheryl Waters; Stanley Fahn; Tsvyatko Dorovski; Wendy K Chung; Michael Pauciulo; William Nichols; Huma Q Rana; Manisha Balwani; Louise Bier; Deborah Elstein; Ari Zimran
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

2.  Prevention of lysosomal storage diseases and derivation of mutant stem cell lines by preimplantation genetic diagnosis.

Authors:  Gheona Altarescu; Rachel Beeri; Rachel Eiges; Silvina Epsztejn-Litman; Talia Eldar-Geva; Deborah Elstein; Ari Zimran; Ehud J Margalioth; Ephrat Levy-Lahad; Paul Renbaum
Journal:  Mol Biol Int       Date:  2012-12-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.